Stephen R. Seiler
Keine laufenden Positionen mehr
Profil
Stephen R.
Seiler is the founder of AesRX LLC, which was founded in 2010.
He was the President & Chief Executive Officer of Abeona Therapeutics, Inc. in 2007 and the Chief Executive Officer of Idera Pharmaceuticals, Inc. He received his undergraduate degree from the University of Notre Dame in 1977 and his graduate degree from Georgetown University in 1980.
Ehemalige bekannte Positionen von Stephen R. Seiler
| Unternehmen | Position | Ende |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Präsident | 19.12.2007 |
AesRX LLC
 AesRX LLC Pharmaceuticals: MajorHealth Technology AesRx LLC is a biopharmaceutical company. The firm develops pharmaceutical products for the treatments for two orphan diseases. It offers Aes-103, a is targeted to the treatment of sickle cell disease. The company was founded by Stephen Seiler on November 22, 2010 and is headquartered in Newton, MA. | Gründer | - |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Präsident | - |
Ausbildung von Stephen R. Seiler
| University of Notre Dame | Undergraduate Degree |
| Georgetown University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
AesRX LLC
AesRX LLC Pharmaceuticals: MajorHealth Technology AesRx LLC is a biopharmaceutical company. The firm develops pharmaceutical products for the treatments for two orphan diseases. It offers Aes-103, a is targeted to the treatment of sickle cell disease. The company was founded by Stephen Seiler on November 22, 2010 and is headquartered in Newton, MA. | Health Technology |
